Jet Generici

Jet Generici is an Italian pharmaceutical company specializing in the development and distribution of generic medicinal products. Headquartered in Milan, the company offers a comprehensive portfolio of high-quality, bioequivalent medications across several key therapeutic areas, including cardiovascular, respiratory, and central nervous system disorders. In 2018, Jet Generici was acquired by the German-based Aristo Pharma Group, a move that significantly expanded its manufacturing resources and market reach. The company focuses on providing cost-effective healthcare solutions to the Italian market, working closely with pharmacies and healthcare providers to improve patient access to essential treatments. Its business model is built on the reliability of its supply chain and the clinical equivalence of its generic formulations to brand-name drugs.